Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 
Project Element Element Description

Project Title

Project Title

Trial of a glutamate antagonist in the treatment of OCD and autistic disorders

Principal Investigator

Principal Investigator

Swedo, Susan

Description

Description

Riluzole, a glutamate antagonist, reduces symptoms in adults with obsessive-compulsive disorder (OCD). Preliminary data will be collected on Riluzole efficacy and safety in children and adolescents with co-morbid conditions of ASD and OCD.

Funder

Funder

National Institutes of Health

Fiscal Year Funding

Fiscal Year Funding

770674

Current Award Period

Current Award Period

Ongoing

Strategic Plan Question

Strategic Plan Question

Question 4: Which Treatments And Interventions Will Help?

Strategic Plan Objective

Strategic Plan Objective

Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4LA. Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.

Project Link

Project Link

Trial of a glutamate antagonist in the treatment of OCD and autistic disorders (External web link)

Institution

Institution

National Institutes of Health

State/Country

State/Country

Maryland

Project Number

Project Number

1ZIAMH002913-03

Federal or Private?

Federal or Private?

Federal

Received ARRA Funding?

Received ARRA Funding?

No

History/Related Projects

History/Related Projects

N/A

 
Back to Top